Alector Inc (NAS:ALEC)
$ 1.78 -0.04 (-2.2%) Market Cap: 174.32 Mil Enterprise Value: -244.33 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 50/100

Alector Inc at Bank of America NAPA Healthcare Conference Transcript

Jun 14, 2021 / 09:30PM GMT
Release Date Price: $21.19 (+8.00%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Okay. Welcome to the afternoon sessions of the Second Annual Virtual Napa conference. Next here will be the real thing. Fingers crossed. My name is Geoff Meacham, I'm the senior biopharma analyst here, and I have Alex Hammond from my team with me as well. And we're thrilled to have Alector with us for this last session and speaking on behalf of Alector is President and COO, Shehnaaz Suliman. How are you doing, Shehnaaz? It's good to see you.

Shehnaaz Suliman
Alector, Inc. - President, COO & Interim Chief Business Officer

Doing great. Thanks for having us.

Questions & Answers

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Yes. So we'll start it off with maybe just sort of a recap of the events of early last week with Biogen's aducanumab obviously, doesn't directly affect you, but I wanted to kind of get your thoughts of the FDA decision and maybe what that means for Alzheimer's or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot